Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukiko Izumi is active.

Publication


Featured researches published by Yukiko Izumi.


Autoimmunity | 2001

Characteristics of experimental autoimmune hypophysitis in rats : Major antigens are growth hormone, thyrotropin, and luteinizing hormone in this model

Kiyoshi Watanabe; Hisato Tada; Yuki Shimaoka; Yoh Hidaka; Ke-ita Tatsumi; Yukiko Izumi; Nobuyuki Amino

We produced experim entalautoimmune hypophysitis (EAH) in rats and investi gated its characteristics. Female Lewis rats were immunized by two injections with homologous pituitary homogenate and complete Freund’s adjuvant. Blood was coll ected seri ally from the rats, and serum antibodies to pituitary antigens were examined . The rats were sacrificed 2 or 4 weeks after the final immunization, and hi stological examinations of the endocrineorgans were carried out. Hi stolog ical examination revealedslight , focal infiltration of mononuclearcells in the pituitary gland only in the rats immunized with the pituitary homogenate. Infiltration of mononuclearcells was not observed in the thyroidgland , pancreas, adrenal gland , or ovary. In the serological examination, antibodies to bothcytoso licantigens and cytoplas micparticle a nti gens from the pituitaryg land were detected by enzyme- linked immunosorbent assay (ELISA), and these antibody levels increased with time. We stern blottingusing the sennn antibodiesidentified an immunoreactive protein of -2 1.5 k.Daamo ng these antigens, and we confirmed that this protein was ratgrow thhormone (GH). Furth ermore, antibodies to GH, thyrotropin (TSH), and luteinizing hormone (LH) were detected by E LISA. Antibodies to folli cule stimulating horm one, prol actin , or adrenocorticotropin were not detected . These data suggest that several antigens from the pituitary gland are involved in EAH inrats, and that GH, TSH, and LH are major antigens among the pituitary antigens in this model.


Clinical Endocrinology | 2003

Blocking‐type anti‐TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves’ disease

Hisato Tada; Ikuko Mizuta; Toru Takano; Ke-ita Tatsumi; Yukiko Izumi; Yoh Hidaka; Nobuyuki Amino

objective Antithyroid drugs are effective in some patients with Graves’ disease but not in others. The factors responsible for this difference are still unknown. We examined the relationship between the nature of anti‐TSH receptor (TSH‐R) antibodies and responsiveness to drugs in Graves’ disease.


Journal of Internal Medicine | 2002

Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases

Yukiko Izumi; Akira Kaneko; Kazumi Oku; Masahiro Kimura; Susumu Tanaka; Hisato Tada; Ke-ita Tatsumi; Toru Takano; Yoh Hidaka; Nobuyuki Amino

Autoimmune diseases, especially autoimmune thyroid disease, frequently develop after delivery due to the immune rebound mechanism. Most cases involve transient dysfunction of affected organs. Weexamined three patients who developed liver dysfunction after delivery. They were all diagnosed with definite or probable autoimmune hepatitis using the scoring system of the International Autoimmune Hepatitis Group. Moreover, all of them had anti‐CYP2D6 antibodies detected by a sensitive radioligand assay. Our findings strongly suggest that liver dysfunction is induced by postpartum autoimmune hepatitis, and clinicians should be aware of this disease.


Clinica Chimica Acta | 2002

Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.

Masahiro Kimura; Ke-ita Tatsumi; Hisato Tada; Yukiko Izumi; Akira Kaneko; Michio Kato; Manabu Masuzawa; Masaki Ikemoto; Yoshiyasu Yabusaki; Yoh Hidaka; Nobuyuki Amino

BACKGROUND Antibodies to cytochrome P4502D6 (CYP2D6) were measured and their prevalence compared with that of antibodies to liver-specific arginase in patients with autoimmune hepatitis (AIH). METHODS Anti-CYP2D6 antibodies were measured by sensitive radioligand assay and enzyme-linked immunosorbent assay (ELISA), and anti-arginase antibodies were measured by ELISA in 132 patients (definite AIH 11, probable AIH 36, hepatitis C 20, hepatitis B 23, other autoimmune diseases 42) and 50 healthy controls. RESULTS CYP2D6 index (radioligand assay) was significantly higher in all groups of patients than those in healthy controls. A higher index than the cut-off value (mean+3 S.D. in healthy controls) was found in 36.4%, 44.4%, 25.0%, 17.4% and 28.6% of patients with definite AIH, probable AIH, hepatitis C, hepatitis B and other autoimmune diseases, respectively. CYP2D6 index was not related to serum IgG, anti-nuclear antibody or AIH scores, and was weakly correlated with anti-arginase antibody activity. When CYP2D6 index and anti-arginase antibodies were combined, 55.3% of AIH patients were positive for either one or both antibodies. CONCLUSIONS Anti-CYP2D6 antibodies by radioligand assay were frequently present in patients with AIH. Combined tests for anti-CYP2D6 radioligand assay and anti-arginase antibodies resulted in detection of 55% of AIH patients.


American Journal of Reproductive Immunology | 2003

Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies.

Yukiko Izumi; Susumu Tanaka; Yoh Hidaka; Yuki Shimaoka; Ke-ita Tatsumi; Toru Takano; Akira Kaneko; Kazumi Oku; Nobuyuki Amino

Problem:  Autoimmune thyroid disease frequently aggravates or develops after delivery through the immune rebound mechanism. However, little is known about the post‐partum development of autoimmune hepatitis (AIH).


Endocrine Journal | 2000

Postpartum Autoimmune Thyroid Syndrome

Nobuyuki Amino; Hisato Tada; Yoh Hidaka; Yukiko Izumi


Clinical Endocrinology | 2002

Simple and practical parameters for differentiation between destruction‐induced thyrotoxicosis and Graves’ thyrotoxicosis

Yukiko Izumi; Yoh Hidaka; Hisato Tada; Toru Takano; Taku Kashiwai; Ke-ita Tatsumi; Kiyoshi Ichihara; Nobuyuki Amino


The Journal of Clinical Endocrinology and Metabolism | 2003

No Increase of Blocking Type Anti-Thyrotropin Receptor Antibodies During Pregnancy in Patients with Graves’ Disease

Nobuyuki Amino; Yukiko Izumi; Yoh Hidaka; Keiko Takeoka; Yukiko Nakata; Ke-ita Tatsumi; Atsuo Nagata; Toru Takano


Endocrine Journal | 2003

Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease.

Taku Kashiwai; Yoh Hidaka; Toru Takano; Ke-ita Tatsumi; Yukiko Izumi; Yuki Shimaoka; Hisato Tada; Keiko Takeoka; Nobuyuki Amino


Endocrine Journal | 2001

Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism.

Noriko Tagawa; Toru Takano; Shuji Fukata; Kanji Kuma; Hisato Tada; Yukiko Izumi; Yoshiharu Kobayashi; Nobuyuki Amino

Collaboration


Dive into the Yukiko Izumi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge